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Background and Aims. Balloon-assisted enteroscopy (BAE) is a well-established tool in the diagnosis and therapy of small bowel
diseases. Ink tattooing of the small bowel is used to mark pathologic lesions or the depth of small bowel insertion. The purpose
of this study was to determine the safety, the detection rate, and the clinical relevance of ink tattooing during BAE. Methods. We
performed a retrospective analysis of all 81 patients who received an ink tattooing during BAE between 2010 and 2015. Results.
In all patients, ink tattooing was performed with no complications. 26 patients received a capsule endoscopy after BAE. The
tattoo could be detected via capsule endoscopy in 19 of these 26 patients. The tattoo of the previous BAE could be detected via
opposite BAE in 2 of 11 patients. In 9 patients, ink tattooing influenced the choice of approach for reenteroscopy. In 7 patients,
the tattoo was used for intraoperative localization and in 3 patients for intraoperative localization as well as for reenteroscopy.
The intraoperative detection rate of the tattoo was 100%. Conclusion. Ink tattooing of the small intestine is a safe endoscopic
procedure to mark the depth of scope insertion or a pathologic lesion during balloon-assisted enteroscopy.
1. Introduction
Endoscopic tattooing is an old and well-established tool
for marking of pathologic lesions in the colon. The tech-
nique was first described for sigmoidoscopy by Sauntry and
Knudston in 1958 [1]. Tattooing with India ink was first
described in 1975 [2]. Over the years, the technique was
improved and has been shown to be a safe procedure. Com-
plications occur only rarely [3]. The main complications
described in the literature are associated with the transmural
injection of the ink inducing inflammatory processes such as
peritonitis, small bowel infarction, and abscesses [2, 4].
Double-balloon-assisted enteroscopy (DBE) was devel-
oped in 2001 by Yamamoto. It makes a complete enteroscopy
with therapeutic intervention in the small intestine possible
[5, 6]. Due to missing landmarks of the small intestine, India
ink was used for small bowel tattooing. By using ink tattooing
as a landmark, Yamamoto et al. were able to demonstrate
complete enteroscopy by an antegrade and a retrograde
approach in 24 of 28 patients (86%) [5]. Single-balloon
enteroscopy (SBE) was introduced in 2007 with similar
insertion depths and adverse events as compared to DBE
[7, 8]. The main indications for performing an enteroscopy
of the small intestine are suspected or known gastrointestinal
bleeding and for the evaluation of suspected or known polyps
or tumors of the small intestine. Other indications include
the DBE-assisted endoscopic retrograde cholangiopancreato-
graphy (ERCP) in patients with altered upper gastrointestinal
anatomy, such as Roux-en-Y gastric bypass [9].
However, adequate data concerning ink tattooing of the
small intestine has not yet been published.
The purpose of this retrospective study was to examine
the safety, the detection rate during a surgical operation or
video capsule endoscopy, and the clinical relevance of ink
tattooing during balloon-assisted enteroscopy (BAE).
2. Methods
2.1. Study Population. All patients who received a BAE from
January 01, 2010, to December 31, 2015, were considered
eligible for inclusion in this study. The inclusion criterion
was an ink tattooing of the small intestine during the
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examination. The study was conducted in accordance with
the ethical principles of the Declaration of Helsinki and in
compliance with good clinical practice and local regulations.
2.2. Endoscopic Procedure. An informed consent was
obtained from all patients after providing them with ade-
quate information on possible complications associated with
the procedure such as dental injuries, bleeding, perforation,
cardiovascular failure due to sedation, and allergic reaction.
All patients were sedated with midazolam and when neces-
sary, in combination with Disoprivan (propofol). In some
cases, additional pethidine was given.
2.3. Ink Tattooing Procedure. Ink tattooing was performed
with an injection needle through the working channel of the
endoscope. The InjectorForce Max (Olympus, Hamburg
Germany) with a working length of 2700mm, needle diame-
ter of 0.6mm, and a needle length of 4mm as well as the
MANTA injection needle (Medwork, Höchstadt, Germany)
with a working length of 2400mm, needle diameter 0.7mm,
and a needle length of 5mm was used. First, the needle was
flushed with saline solution. Then, the needle was advanced
to the submucosal layer of the small bowel. The first injection
was performed with saline solution until a submucosal cush-
ion was observed. The ink was then injected into the submu-
cosal cushion thereby reducing the risk of a transmural
administration of the ink. With this method, inflammatory
complications such as abscess or peritonitis become unlikely.
A few milliliters of injected ink was usually sufficient for the
tattooing procedure (Figure 1). If a tumor or polyp was
marked with an ink tattoo, the tattoo was regularly placed
proximal to the lesion site.
We used the ink Black Eye (The Standard, Seoul, Korea),
which, in contrast to original nonsterile India ink, is sterile.
Furthermore, it has a high purity of suspended carbon parti-
cles, whereas India ink often contains impurities such as phe-
nols, ammonia, and animal products.
The material costs for the application of an ink tattoo in
one patient, including a needle, ink, and saline solution,
amount to about 50€ (60 US$) without tax.
2.4. Analysis. A clinical or therapeutic consequence of the ink
tattooing procedure was assumed when the tattoo was used
during surgery to identify the pathologic lesion which had
been marked previously. Also, when the ink tattoo influenced
the choice of a subsequent endoscopic examination as was
the case in patients with a second bleeding episode in
whom a capsule endoscopy and then a second BAE was
performed within the study period (January 01, 2010, to
December 31, 2015).
3. Results
The present study is a retrospective open-label single-center
analysis at Klinikum Augsburg. Between January 01, 2010,
and December 31, 2015, 229 BAE were performed in 156
patients at the endoscopy unit of Klinikum Augsburg. 26 of
these 229 examinations were performed as a single-balloon
enteroscopy, the rest was done using the double-balloon
technique. 171 BAE were performed with an antegrade and
58 with a retrograde approach. The indications for BAE were
Crohn’s disease (20 patients), angiodysplasia (47 patients),
suspected gastrointestinal bleeding (43 patients), anemia
(30 patients), known or suspected tumor or polyps (30
patients), and other indications such as Meckel’s diverticu-
lum, invagination, unspecified ulcers, foreign bodies, stenosis
of the small intestine, and search of the major duodenal
papilla after a gastrojejunostomy (30 patients).
11 patients had to be excluded because the BAE
achieved no deeper intubation of the small intestine with
its push-and-pull principle compared to the conventional
endoscopy. Four patients had to be excluded because of a
respiratory depression under sedation. One patient was
excluded because of age under 18 years. In 59 BAE, no ink
tattooing was performed and the patients were therefore
excluded. Thus, 81 patients met the entry criteria. 73
patients received a BAE with an antegrade and eight
patients with a retrograde approach. The median age of
the patients was 69 years (range 23–92). In all 81 patients,
ink tattooing of the small intestine was performed without
any complications. Five patients had to be excluded over
the course of time (see also Figure 2). Two patients aborted
their stay in our hospital, and three patients suffered under
severe worsening of their health condition so that in accor-
dance with their will no further diagnostic or therapeutic
steps were taken.
In 27 patients (33%), no pathologic finding was discov-
ered during the BAE examination. In 35 patients, angiodys-
plasia (43%) was found and treated in 26 cases with APC
and in nine cases with a clip. Further findings were hemangi-
oma (2 patients, 2%), ulcers and other inflammatory lesions
(7 patients, 9%), and tumor and polyps (11 patients, 14%)
as well as ulcerative diverticula (1 patient, 1%). Two patients
showed two different pathologic findings during the BAE;
in four patients, the pathologic lesions showed an active
bleeding (see Table 1).
Follow-up was defined as any further endoscopic exami-
nation of the gastrointestinal tract (including capsule entero-
scopy) within the study period. No follow-up was performed
in five patients who underwent surgery directly after entero-
scopy and in one patient due to his poor clinical condition.
46 of 81 patients (57%) received further examinations.
Further diagnostic was needed in 24 patients due to a
rebleeding episode and in 6 patients for follow-up monitor-
ing of a polyp/tumor. In 11 patients, a further examination
was indicated as a second look for completion of the APC
therapy or for an approach from the opposite side. One
patient needed a second examination because of Crohn’s dis-
ease and in four cases, the suspected pathologic lesion was
not found in the BAE (see Figure 2).
15 of 46 received no further examination of the small
intestine. Two patients received no further diagnostic exam-
ination of the small intestine because they underwent surgery
and one because of his poor clinical condition (see Figure 2).
A typical case report is shown in Figure 3.
31 patients received further examinations of the small
intestine, and 20 patients with a second BAE. 13 patients
were followed up with a BAE using an antegrade approach.
12 of these patients had already received an antegrade BAE.
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One of these patients initially received a retrograde BAE. The
ink tattoo of the previous BAE was reached in eight cases
with the following BAE; in three cases, a further ink tattooing
was performed. One patient received an antegrade BAE after
an initial retrograde approach. The ink tattoo was not
reached and a new tattoo was placed. 15 patients were
planned for a BAE with a retrograde approach as a follow-
up examination. However, in five patients, intubation of the
terminal ileum during retrograde BAE was not achieved.
The remaining ten patients had initially had a BAE with
an antegrade approach. The ink tattoo of the previous
opposite BAE was reached in only two patients. Five
patients received a second ink tattoo. Three patients under-
went surgery after these further diagnostic steps, and another
three patients had to be excluded due to their clinical situation
(see Figure 2).
In total, 26 patients received a capsule endoscopy after
BAE with ink tattooing. In 19 of these 26 patients (73%),
the ink tattoo was detected in the capsule endoscopy. The
detection of the tattoo via VCE determined the approach of
reenteroscopy in 12 of 19 cases (63%) (see Figure 4).
In summary, 90 ink tattooing procedures were performed
in 81 patients without any complications. Ink tattooing had a
clinical or a therapeutic consequence in 19 of 81 patients
(23%). In 12 patients, the ink tattoo was used in the follow-
up for the choice of an antegrade or retrograde approach.
In ten cases, the ink tattoo facilitated the localization of the
area of interest during surgery (see Figure 4). Nine of these
ten patients who underwent surgery had a tumor of the small
intestine, and active bleeding was seen in two patients. One
patient was operated due to recurrent bleeding from heman-
gioma in the small intestine. In three patients, the ink tattoo
was used for further endoscopies as well as for surgery over
the course of time. The ink tattoo could be detected via cap-
sule endoscopy in 73% of cases (see Figure 4). A complete
enteroscopy was achieved only in two of 11 patients (18%)
with an antegrade as well as a retrograde approach. Neither
patients had a history of abdominal surgery.
(a) (b)
(c) (d)
Figure 1: Technique of ink injection. Ink tattooing of the small bowel during a balloon-assisted enteroscopy. The injection needle is placed on
the small bowel surface (a). After penetration of the mucosal layer of the small intestine, saline solution is injected and a submucosal lifting can
be observed (b). Subsequently, the ink is injected into the submucosal cushion and under endoscopic view (c). After ink injection, the needle is
retracted and the tattoo is documented (d).
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4. Discussion
India ink for tattooing of the gastrointestinal tract was first
used in the colon, where it was shown to be a safe procedure
with a clinical complication rate below 1% [1, 3]. At the
introduction of the DBE by Yamamoto et al., India ink was
used for marking the depth of insertion into the small intes-
tine [5]. Since then, ink tattooing of the small intestine has
been used routinely for marking pathologic lesions or the
depth of insertion. However, no adequate data concerning
ink tattooing of the small intestine has been published so
far. Ink tattooing was performed in our study 90 times in
the small intestine without any complications. Our study is
the first study showing the safety of ink tattooing of the
small intestine.
A large meta-analysis in 2016 showed that ink tattooing
of colorectal cancers within a colonoscopy leads to fewer
Table 1: Demographic and clinical characteristics.
Parameter
Age (years) 69 [23–92]
Sex (male/female) 58/23
BAE with primary ink
tattooing(antegrade/retrograde)
81 [73/8]
No pathologic finding 27 (33%)
Angiodysplasia 35 (43%)
Hemangioma 2 (2%)
Ulcers/inflammatory lesions 7 (9%)
Tumor/polyps 11 (14%)
Ulcerative diverticula 1 (1%)
Two pathologic findings within the BAE 2
Active bleeding of the pathologic finding 4
75 pts: excluded due to missing ink 
tattooing
35 pts: with no follow-upendoscopy
underwent surgery




156 pts with 229 BAE
81 pts with ink tattooing
46 pts with further follow-up 
15 pts: without further examinations
of the small intestine
underwent surgery




3 pts: antegrade BAE + retrograde BAE





(ii) 2/3 pts: 
(iii) 1 pt:
10 pts: antegrade BAE 




excluded due to clinical
situation
(ii) 6/9 pts:
(iii) 1 pt: 
7 pts: retrograde BAE 
(i) 2/7 pts: complete enteroscopy
underwent surgery
excluded due to clinical
situation 
(ii) 1 pts: 
(iii) 1 pt: 
20 pts with further enteroscopy of the small intestine 
31 pts with follow-up of the small intestine
11 pts: received further capsule
endoscopy alone
underwent surgery




Figure 2: Flowchart of 229 balloon-assisted enteroscopies in 156 patients for small intestine diagnostics at our endoscopic unit. BAE: balloon-
assisted enteroscopy; pts: patients.
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localization errors during surgery. Therefore, the authors
recommend a routine use of ink tattooing of pathologic
lesions in the colon prior to operation [10]. In our study,
the intraoperative localization of the pathologic lesion was
facilitated by the earlier performed ink tattoo. In all ten cases
(100%) that underwent surgery, the area of interest was
recognized by the surgeon due to the ink tattoo. Similar to
the recommendation of Acuna et al. [10] in the colon, we
suggest ink tattooing of all tumors of the small intestine
detected during enteroscopy.
The most common indication for an examination of the




Figure 3: Typical case report. A 64-year-old woman was transferred to our hospital with suspected midgastrointestinal bleeding. The patient
had a history of a MALT lymphoma. An externally performed colonoscopy as well as gastroscopy showed no pathologic finding. A capsule
endoscopy was performed (a and b) showing a submucosal tumor with an ulceration on the surface. A DBE with an antegrade approach
showed no pathologic findings. In the retrograde DBE, several submucosal tumors could be found (c and d). The histological
examinations showed a carcinoid tumor. The patient received a resection of a small bowel segment after a DOTATE-PET-CT scan was
performed (e). (a and b) Pictures of the findings of the video capsule endoscopy balloon-assisted enteroscopy. (c and d) Pictures of the
retrograde DBE. (e) Intraoperative preparation. Clearly visible is the ink tattoo on the left side which was used as an intraoperative landmark.
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cases [11, 12]. This rate is in accordance to our findings with
77% gastrointestinal bleeding, anemia, or known angiodys-
plasia. Our data shows that an ink tattoo is especially helpful
in such patients with angiodysplasia or bleeding hemangi-
oma. If rebleeding occurs, the marking can be used after
a video capsule endoscopy for the choice of approach for sub-
sequent balloon-assisted enteroscopy. This was the case in the
majority (63%) of ink tattoos detected via VCE in our study.
The rate of complete visualization of the small intestine
with balloon enteroscopy with an antegrade and retrograde
approach was 18% in our study. This rate differs largely
form initially published data, where a complete visualiza-
tion rate of 86% for DBE was achieved [5]. However,
results of further published data show completion rates
comparable to our results [13–16]. Our retrospective data
indicates that in clinical reality and beyond the setting of
study situations such a high completion rate seem unlikely.
Most of the available literature indicates a better complete
visualization rate of the small intestine for DBE compared
to SBE [6, 7, 16–20]. However, it remains a subject of
ongoing discussions, whether a complete enteroscopy is nec-
essary to improve the diagnostic yield or to influence further
therapeutic decisions [18, 20–22]. Nonetheless, a better and
more complete inspection with the possibility of immediate
endoscopic treatment of findings could be relevant for the
outcome of patients suffering from such ailments as angio-
dysplasia or polyposis syndromes [21].
Adverse events through a DBE (1.6%) or SBE (2.2%)
examination occur only rarely [7]. In our study, no adverse
events occurred as a result of enteroscopy.
Beside the balloon-assisted push-and-pull-principle,
another principle used is the so-called spiral enteroscopy
(SE). The principal of SE involves scope insertion by rotation
of a flexible overtube which is placed over a standard entero-
scope. Initial data has shown lower or equal complete visual-
ization rates for the SE compared to the DBE [16, 23]. A new
endoscope with an integrated motorized spiral system has
been developed for spiral enteroscopy and is in the phase of
clinical testing [11]. It is unclear how significant the impact
of SE will be on the completion rate in clinical reality.
The study limitations are its retrospective, electronic
data-based, and single-center design. Therefore, ink tattooing
of the small intestine may actually have a higher rate of clin-
ical or therapeutic consequences than the 23% shown in this
study. The reason for this assumption is based on the fact
that due to the study design, the follow-up period may have
been too short and some patients may not have been
observed sufficiently.
5. Conclusion
In summary, ink tattooing of the small intestine is a min-
imally invasive and safe endoscopic procedure to mark the
depth of scope insertion or a pathologic lesion. It is a use-
ful tool which facilitates the intraoperative localization of
pathologic lesions and influences the choice of approach
of a reenteroscopy, when indicated. The detection rate of
the ink tattoo with the video capsule was significant. The
intraoperative detection rate of the ink tattoo was 100%.
A complete enteroscopy of the small intestine via BAE
from a retrograde and an antegrade approach was rarely
achieved in our clinical setting.
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